Intrinsiqs

Is Ionis Pharmaceuticals, Inc. overvalued?

Ionis Pharmaceuticals, Inc. (IONS) — key valuation metrics and fundamentals.

No verdict
Price
$81.14
Fair value
Current P/E
Normal P/E
Market cap
$13.42B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares IONS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.